Management Team
Name: Alex Gorsky
Biography: Alex Gorsky is Worldwide Chairman, Medical Devices & Diagnostics at Johnson & Johnson, a role he assumed in September 2009. He has been a member of the Executive Committee since January 2009.
Alex began his Johnson & Johnson career as a sales representative with Janssen Pharmaceutica Inc in 1988. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing and management, and was named President of Janssen Pharmaceutica Inc. in the U.S. His accomplishments included the commercial development of RISPERDAL® (risperidone), DURAGESIC®/DUROGESIC® (fentanyl transdermal system), ACIPHEX®/PARIET® (rabeprazole sodium) and REMINYL®/RAZADYNE® (galantamine HBr). In 2003, Alex was promoted to company group chairman for the Johnson & Johnson Family of Companies pharmaceutical business in Europe, the Middle East and Africa. Alex left Johnson & Johnson in 2004 to serve as the chief operating officer for Novartis Pharmaceuticals Corporation. In 2005 he was named Head of Pharma North America and Chief Executive Officer for Novartis. Under his leadership, Novartis received approval for and launched a number of key new products. Alex was also instrumental in the successful launch at Novartis of Medicare Part D to ensure access for seniors, and he started that company's CEO Award for Diversity and Inclusion.
Alex holds a Bachelor's of Science degree from the U.S. Military Academy in West Point, N.Y., and spent six years in the U.S. Army, finishing his career with the rank of Captain. During that same time, he earned the Ranger Tab, Airborne Wings, and served in Europe, the United States, and Panama. He obtained a Master's in Business Administration from The Wharton School of the University of Pennsylvania in 1996.
Alex is actively involved in the National Alliance for the Mentally Ill, The National Alliance on Aging, the Philadelphia College of Pharmacy, the Doylestown Hospital Board, and the Boy Scouts of America.
